Send feedback

ATL2 p.Pro548Ser

c.1642C>T · rs781044136 · VCV3131063

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.6596 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0417%, sas)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense0.6596likely pathogenic
REVEL0.625indeterminate
SaProtLLR -9.98tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 10GERP 1.5, phastCons 1
Regional constrainto/e 1.05unconstrained · MANE · 81 kb · p 0.18 · regional, not allelic
Overall
CADD25.1PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0417% South Asian · 35/83,908 alleles
Filtering AF 0.0308% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.027%
Overall 0.00265% 37/1,398,318 alleles · ultra-rare
Ancestry group Frequency 1 in
South Asiangrpmax 0.0417% 2,397
Remaining individualsnot grpmax-eligible 0.00333% 30,040

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ATL2
Protein
p.Pro548Ser
Coding
c.1642C>T
MANE Select
NM_001135673
dbSNP
rs781044136
Type
single nucleotide variant
Location
chr2:38296104 (GRCh38)
Gene constraint
LOEUF 0.647 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 84.36
Residue 548
the 'autoinhibitory domain' region
Full ATL2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/atl2-p-pro548ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown